Table 3.

Prevalence of anal canal HPV infection among men who have sex with women (MSW) by BMI in the HIM study.

	No. % (95% CI)
HPV typea	Normal weight (n = 556)			Overweight (n = 531)			Obese (n = 261)			Total (n = 1348)
Any HPV type	66	11.9	(9.3–14.9)	73;13.7		(10.9–17.0)	28	10.7	(7.2–15.1)	167	12.4	(10.7–14.3)
Any high-risk type	38	6.8	(4.9–9.3)	40	7.5	(5.4–10.1)	15	5.7	(3.3–9.3)	93	6.9	(5.6–8.4)
Any low-risk type	39	7.0	(5.0–9.5)	48	9.0	(6.7–11.8)	16	6.1	(3.5–9.8)	103	7.6	(6.3–9.2)
2vHPV types	8	1.4	(0.6–2.8)	15	2.8	(1.6–4.6)	8	3.1	(1.3–5.9)	31	2.3	(1.6–3.2)
4vHPV types	13	2.3	(1.3–4.0)	23	4.3	(2.8–6.4)	13	5.0	(2.7–8.4)	49	3.6	(2.7–4.8)
9vHPV types	22	4.0	(2.5–5.9)	33	6.2	(4.3–8.6)	15	5.7	(3.3–9.3)	70	5.2	(4.1–6.5)
High-risk types
16	7	1.3	(0.5–2.6)	14	2.6	(1.4–4.4)	8	3.1	(1.3–5.9)	29	2.2	(1.4–3.1)
18	1	0.2	(0.0–1.0)	1	0.2	(0.0–1.0)	0	0.0	(0.0–1.4)	2	0.1	(0.0–0.5)
31	0	0.0	(0.0–0.7)	4	0.8	(0.2–1.9)	0	0.0	(0.0–1.4)	4	0.3	(0.1–0.8)
33	2	0.4	(0.0–1.3)	0	0.0	(0.0–0.7)	0	0.0	(0.0–1.4)	2	0.1	(0.0–0.5)
45	3	0.5	(0.1–1.6)	2	0.4	(0.0–1.4)	0	0.0	(0.0–1.4)	5	0.4	(0.1–0.9)
52	3	0.5	(0.1–1.6)	2	0.4	(0.0–1.4)	0	0.0	(0.0–1.4)	5	0.4	(0.1–0.9)
58	2	0.4	(0.0–1.3)	2	0.4	(0.0–1.4)	2	0.8	(0.1–2.7)	6	0.4	(0.2–1.0)
Low-risk types
6	6	1.1	(0.4–2.3)	10	1.9	(0.9–3.4)	4	1.5	(0.4–3.9)	20	1.5	(0.9–2.3)
11	0	0.0	(0.0–0.7)	0	0.0	(0.0–0.7)	1	0.4	(0.0–2.1)	1	0.1	(0.0–0.4)

^a HPV genotypes shown are those in the 9vHPV vaccine and those with prevalence of $\ge$ 5.0% for any BMI category.